Predictive Risk Factors of Nonalcoholic Fatty Liver Disease in a Lean Chinese Population

被引:5
作者
Liu, Lu [1 ]
Shi, Xiaolan [1 ]
Gao, Jingwen [1 ]
Xu, Chunfang [1 ]
Liu, Xiaolin [1 ]
机构
[1] Soochow Univ, Affiliated Hosp 1, Dept Gastroenterol, Suzhou 215000, Peoples R China
来源
JOURNAL OF PERSONALIZED MEDICINE | 2022年 / 12卷 / 12期
基金
中国国家自然科学基金;
关键词
non-alcoholic fatty liver disease; lean population; predictive model; nomogram; INSULIN-RESISTANCE; METABOLIC SIGNIFICANCE; HEPATIC STEATOSIS; HIGH PREVALENCE; POTENTIAL-ROLE; NONOBESE; FIBROSIS; NASH; STEATOHEPATITIS; PATHOGENESIS;
D O I
10.3390/jpm12121958
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Although nonalcoholic fatty liver disease (NAFLD) is related to obesity, it may also affect lean individuals. Recent data suggest that lean NAFLD patients can develop the whole spectrum of NASH. However, the NAFLD predictive model for lean populations remains lacking. Methods: A total of 5037 lean individuals were included in this study, and the data were separated for training and validation. The logistic regression method was used, and a nomogram, a type of prediction model, was constructed according to the logistic regression analysis and the significant clinical factors. The performance of this model was evaluated based on its discrimination, calibration, and clinical utility. Results: The individuals were divided into the training (n = 4068) or validation (n = 969) cohorts at a ratio of 8 to 2. The overall prevalence of NAFLD in the lean cohort was 6.43%. The nomogram was constructed based on seven predictors: alanine aminotransferase, total cholesterol, triglycerides, low-density lipoprotein cholesterol, creatinine, uric acid, and hemoglobin A1C. The model based on these factors showed good predictive accuracy in the training set and in the internal validation set, with areas under the curve (AUCs) of 0.870 and 0.887, respectively. The calibration curves and decision curve analysis (DCA) displayed good clinical utility. Conclusion: the nomogram model provides a simple and reliable ability to predict the risk of NAFLD in lean subjects. The model can predict lean NAFLD and can help physicians screen and identify lean subjects at a high risk of NAFLD.
引用
收藏
页数:10
相关论文
共 47 条
[1]   DISCOVERING PATHWAYS OF SARCOPENIA IN OLDER ADULTS: A ROLE FOR INSULIN RESISTANCE ON MITOCHONDRIA DYSFUNCTION [J].
Abbatecola, A. M. ;
Paolisso, G. ;
Fattoretti, P. ;
Evans, W. J. ;
Fiore, V. ;
Dicioccio, L. ;
Lattanzio, F. .
JOURNAL OF NUTRITION HEALTH & AGING, 2011, 15 (10) :890-895
[2]   Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels [J].
Akyuz, Umit ;
Yesil, Atakan ;
Yilmaz, Yusuf .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (03) :341-346
[3]   Nonalcoholic fatty liver disease in lean and obese patients in Saudi patients from a single center [J].
Alsuhaibani, Khalid A. ;
Althunayyan, Faris S. ;
Alsudays, Ali M. ;
Alharbi, Ahmad A. ;
Aljarallah, Badr M. .
JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2021, 10 (09) :3381-3386
[4]   Nonalcoholic Fatty Liver Disease-Related Cirrhosis Is Commonly Unrecognized and Associated With Hepatocellular Carcinoma [J].
Bertot, Luis C. ;
Jeffrey, Gary P. ;
Wallace, Michael ;
MacQuillan, Gerry ;
Garas, George ;
Ching, Helena L. ;
Adams, Leon A. .
HEPATOLOGY COMMUNICATIONS, 2017, 1 (01) :53-60
[5]   Chronic low-grade inflammation and age-related sarcopenia [J].
Beyer, Ingo ;
Mets, Tony ;
Bautmans, Ivan .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2012, 15 (01) :12-22
[6]   Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis [J].
Brown, Gregory Thomas ;
Kleiner, David E. .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08) :1080-1086
[7]   Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: Metabolic significance of nonalcoholic fatty liver disease in nonobese adults [J].
Chen, Chien-Hua ;
Huang, Min-Ho ;
Yang, Jee-Chun ;
Nien, Chiu-Kue ;
Yang, Chi-Chieh ;
Yeh, Yung-Hsiang ;
Yueh, Sen-Kou .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2006, 40 (08) :745-752
[8]   Prevalence of elevated liver stiffness in patients with type 1 and type 2 diabetes: A systematic review and meta-analysis [J].
Ciardullo, Stefano ;
Perseghin, Gianluca .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 190
[9]   Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes [J].
Ciardullo, Stefano ;
Perseghin, Gianluca .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 121
[10]   High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among US Adults With Type 2 Diabetes [J].
Ciardullo, Stefano ;
Monti, Tommaso ;
Perseghin, Gianluca .
DIABETES CARE, 2021, 44 (02) :519-525